Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily

NCT03067415 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Primary Open Angle
Ocular Hypertension

Interventions

DRUG: D565H(Latanoprost 25㎍/㎖)
DRUG: D565(Latanoprost 50㎍/㎖)

Sponsor

Chong Kun Dang Pharmaceutical